- 全部删除
您的购物车当前为空
CMLD010509 (SDS-1-021) is a highly selective inhibitor of the oncogenic translation program supporting multiple myeloma (MM)-including key oncoproteins such as MDM2, CCND1, MYC, MAF, and MCL-1.

CMLD010509 (SDS-1-021) is a highly selective inhibitor of the oncogenic translation program supporting multiple myeloma (MM)-including key oncoproteins such as MDM2, CCND1, MYC, MAF, and MCL-1.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | ¥ 10,600 | 6-8周 | |
| 50 mg | ¥ 13,800 | 6-8周 | |
| 100 mg | ¥ 17,500 | 6-8周 |
CMLD010509 相关产品
| 产品描述 | CMLD010509 (SDS-1-021) is a highly selective inhibitor of the oncogenic translation program supporting multiple myeloma (MM)-including key oncoproteins such as MDM2, CCND1, MYC, MAF, and MCL-1. |
| 体外活性 | CMLD010509 is a potent and selective translation inhibitor through an eIF4E phosphorylation-independent mechanism. CMLD010509 shows an IC50 below 10 nM for most MM cell lines and induces apoptosis. |
| 别名 | SDS-1-021 |
| 分子量 | 556.4 |
| 分子式 | C27H26BrNO7 |
| CAS No. | 256497-58-2 |
| 密度 | 1.519 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容